Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
234.00    -12.50 (-4.91%)
Bid:
236.00
Ask:
248.00
Spread: 12.00 (5.085%)
Market Cap: £25.69m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Press comment

12 May 2014 10:20

RNS Number : 8324G
Alkane Energy PLC
12 May 2014
Β 

ο»Ώ

Β 

Β 

Β 

12 May 2014

Alkane Energy plc

Β 

Press comment

Β 

Alkane Energy plc (AIM: ALK) notes the press commentary on Saturday 10 May and confirms it is in advanced discussions with Egdon Resources plc ("Egdon") on a potential transaction involving an acquisition of Alkane's onshore shale assets for 40,000,000 ordinary shares in Egdon. As part of the potential transaction Egdon is also proposing to raise Β£7 million at 20 pence per share for working capital purposes.

Β 

The potential transaction and Egdon fundraising remain subject to finalisation. The potential transaction is expected to be conditional on approval of the fundraising by Egdon shareholders. A further announcement will be made in due course.

Β 

Β 

Notes to Editors

For more information please contact:

Β 

Liberum (NOMAD and broker)

Clayton Bush

Tim Graham

Β 

Β 

020 3200 2000

Hudson Sandler

Nick Lyon

Alex Brennan

Β 

020 7796 4133

Β 

Β 

Background information

Β 

Alkane is one of the UK's fastest growing independent power generators. The Company operates mid-sized "gas to power" electricity plants providing both predictable and fast response capacity to the grid. Following the acquisition of the Wheldale power response assets, Alkane now has a total of 90MW of installed generating capacity and an electricity grid capacity of 110MW.

Β 

Alkane's main operations are based on a portfolio of coal mine methane ("CMM") sites. Alkane has the UK's leading portfolio of CMM licences, enabling the Company to extract gas from abandoned coal mines.

Β 

As CMM declines at any one site Alkane retains valuable generating capacity and a grid connection which can be redeployed to power response. Power response sites are connected to mains gas and produce electricity at times of high electrical demand or in order to balance the electricity grid. Alkane now operates 37.5MW of power response on mains gas.

Β 

The Group operates from 24 mid-size (up to 10MW) power plants across the UK, 16 CMM only, 6Β mains gas only, and 2 using both fuel sources. Alkane uses standard modular reciprocating engines to generate the electricity and sells this power through the electricity network. The engine units and other plant are designed to be flexible and transportable allowing additional capacity to be brought onto growing sites and underutilised plant to be moved to new sites to maximise efficiency.

Β 

Alkane has a range of core skills encompassing the entire project development cycle including planning and permitting, sourcing plant and managing the build and commissioning stage. This has enabled Alkane to establish a design, build & operate ("DBO") business for third party clients in the biogas and oil & gas industries.

Β 

The Group has more than 800km2 of acreage under various onshore Petroleum Exploration and Development Licences ("PEDLs"). Alkane retains a 100% interest in the majority of these PEDLs, which extend to all of the hydrocarbons recoverable from these licence areas. This includes any CMM, natural gas, coal bed methane ("CBM") or shale gas.

Β 

More information is available on our website www.alkane.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
SPCATMLTMBBBMII
Date   Source Headline
20th Jan 20147:00 amRNSTrading Update and Notice of Results
16th Jan 20147:00 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 201410:06 amRNSTR-1: Notification of Major Interest in Shares
24th Dec 20131:29 pmRNSTotal Voting Rights
9th Dec 20134:38 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSChange of Nominated Adviser
24th Oct 20131:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20132:15 pmRNSAward of Performance Shares
11th Sep 20137:00 amRNSInterim Results
8th Aug 20137:50 amRNSHolding(s) in Company
8th Aug 20137:50 amRNSHolding(s) in Company
5th Aug 201311:26 amRNSAcquisition of Licence
24th Jul 201310:55 amRNSAcquisition of Licence and Third Party Royalty
9th Jul 20137:00 amRNSNotice of Results and Trading Update
28th May 20133:13 pmRNSHolding(s) in Company
28th May 20132:15 pmRNSAward of Performance Shares
28th May 201310:13 amRNSHolding(s) in Company
24th May 20139:29 amRNSCompletion of Acquisition and Fundraising
24th May 20139:28 amRNSTotal Voting Rights
23rd May 201311:48 amRNSHolding(s) in Company
22nd May 20137:00 amRNSAcquisition and Fundraising
16th May 201310:18 amRNSGrant of SAYE Share Options
1st May 20132:58 pmRNSAppointment of Joint Broker
1st May 20132:36 pmRNSResult of AGM
1st May 20137:00 amRNSAGM Statement and Trading Update
22nd Apr 20137:00 amRNSPublication of Report & Accounts
18th Apr 201311:48 amRNSHolding(s) in Company
12th Apr 201312:54 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNSPreliminary results
6th Feb 201310:09 amRNSHolding(s) in Company
18th Jan 20137:00 amRNSNotice of Results and Trading Update
16th Jan 201310:06 amRNSAdditional Listing
6th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Oct 201212:28 pmRNSHolding(s) in Company
26th Oct 201211:24 amRNSTotal Voting Rights
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 20127:00 amRNSAdditional Listing
11th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:02 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSDirectorate Change
21st Sep 20127:00 amRNSGrant of Share Options
12th Sep 20127:00 amRNSInterim Results
3rd Sep 20128:53 amRNS£1.6m Biogas Contract
29th May 201212:28 pmRNSResult of AGM
29th May 20127:00 amRNSTrading Statement
14th May 20129:59 amRNSHolding(s) in Company
10th May 20129:20 amRNSTotal Voting Rights
8th May 201210:15 amRNSHolding(s) in Company
3rd May 20128:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.